Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice
Open Access
- 1 February 1999
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 23 (3), 203-209
- https://doi.org/10.1038/sj.bmt.1701564